CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 34.90
-0.25 (-0.71%)
Oct 31, 2025, 2:58 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 7.47 billion as of October 31, 2025. Its market cap has decreased by -37.79% in one year.
Market Cap
7.47B
Enterprise Value
5.26B
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.90
Market Cap Chart
Since September 27, 2017, CHO Pharma's market cap has decreased from 15.00B to 7.47B, a decrease of -50.21%. That is a compound annual growth rate of -8.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 7.47B | -32.23% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | 4.57B | 3.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |